Tagged with

As the founder of SMD what was it the prompted you to create this company and what were your objectives at that time? Up until 2003 when I created SMD, I used to be the head of IMS for Ukraine, Moldova and Belarus. As a matter of fact, the majority…

Sperco As the first Ukrainian pharmaceutical company backed by foreign capital, explain to us how the idea of creating “Sperco Ukraine” as a joint-venture with UCRAFARMA emerged? The idea to create a pharmaceutical company such as Sperco Ukraine emerged in 1994 when a group of Spanish investors arrived in Ukraine looking…

Roche Ukraine As a leader responsible for heading Roche’s operations since its establishment of an LLC in Ukraine in 2009, what do you consider have been the main achievements of the company? The last two years have been very important and active for the development of Roche in Ukraine, particularly since we…

Nobel Pharma Ukraine Nobel Pharma has quite a history in the CIS region as this region is becoming increasingly important for the company. What is the company’s story in Ukraine? Nobel Pharma Ukraine has been established 6 years ago, we have finished 5 years of active marketing in Ukraine. First let me provide…

PHARMISA South Africa South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one hand and the developmental infectious diseases, such as HIV, AIDS and TB on the other. South Africa represents 0.4% of the world’s population, yet…

Nycomed South Africa Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an excellent strategic fit for both companies. It significantly strengthened Takeda’s geographic reach outside Japan and the United States, the company’s…

MSD South Africa If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the top ten. What are your aspirations? Our Aspiration is to consistently out grow the Market. With more than 10 brands…

Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes in the market since we first came in 2005? There have been enormous changes in the market since you first came here. First, we…

Roche SA South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the most exciting market he has seen in years. Mr. Fagan was telling us this morning how privileged he is to be part of the…

MC Pharma SA Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC Pharma is a licensed pharmaceutical company and acts as a Holder of the Certificate of Registration (Marketing Authorisation Holder; MAH),…

Pfizer South Africa Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the first South African appointed as a country head for Pfizer’s local operations. What were the good and challenging issues you had to contend with…

South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but the government still needs to tackle issues such as providing adequate public health services. Would you say, from your perspective,…